Abstract
The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.
Original language | English |
---|---|
Pages (from-to) | 426-428 |
Number of pages | 3 |
Journal | Annals of laboratory medicine |
Volume | 32 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2012 Nov |
All Science Journal Classification (ASJC) codes
- Clinical Biochemistry
- Biochemistry, medical